tiprankstipranks
Advertisement
Advertisement

Materialise Swings to Q1 2026 Profit as Medical Growth Offsets Manufacturing Weakness

Story Highlights
  • Materialise posted flat first-quarter 2026 revenue but returned to profit, improving margins, cash generation and net cash while strengthening all segments’ adjusted EBITDA.
  • The company’s medical unit grew as software and manufacturing sales dipped, and Materialise moved to transfer its eyewear business to management, anticipating related Q2 impairment charges.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Materialise Swings to Q1 2026 Profit as Medical Growth Offsets Manufacturing Weakness

Meet Samuel – Your Personal Investing Prophet

Materialise ( (MTLS) ) has provided an announcement.

Materialise NV, a Belgian 3D printing software and services company, operates one of the world’s largest 3D printing facilities and employs a substantial software development team focused on industrial and medical applications. The group targets industries such as healthcare, automotive, aerospace and consumer goods with tailored digital manufacturing and mass-customization solutions.

For the first quarter of 2026, reported on May 2026, Materialise kept revenue roughly flat at €66.3 million versus a year earlier but swung from a net loss to a €1.8 million net profit, supported by higher gross margins and improved financial results. Medical segment sales rose 6.7% while software and manufacturing revenues declined, yet all three segments posted stronger adjusted EBITDA, and the company generated positive free cash flow, reduced gross debt and increased net cash, while agreeing after March 31 to transfer its eyewear business to management and retain a minority stake, a move expected to trigger impairment charges in the second quarter.

The most recent analyst rating on (MTLS) stock is a Buy with a $8.10 price target. To see the full list of analyst forecasts on Materialise stock, see the MTLS Stock Forecast page.

Spark’s Take on MTLS Stock

According to Spark, TipRanks’ AI Analyst, MTLS is a Neutral.

MTLS scores as moderately attractive primarily due to a healthier balance sheet and improving cash generation, supported by constructive 2026 guidance and strong Medical performance plus increasing recurring software revenue. The score is held back by weakening recent top-line/margin trends and a bearish technical setup, while valuation signals are unavailable (no P/E or dividend yield provided).

To see Spark’s full report on MTLS stock, click here.

More about Materialise

Materialise NV is a Belgium-based provider of 3D printing software and services, leveraging more than three decades of additive manufacturing expertise. Its open, end-to-end solutions support sustainable, flexible industrial production and mass personalization across sectors including healthcare, automotive, aerospace, eyewear, wearables, art and design, and consumer goods.

Average Trading Volume: 98,724

Technical Sentiment Signal: Hold

Current Market Cap: $321.3M

For a thorough assessment of MTLS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1